PercipEnz Releases OnCore Clinical and Translational Research Software, Version 10.0
This year’s release of the OnCore Clinical and Translational Research Software, Version 10.0, incorporates work done in eight collaborative projects with research organizations across the country.
“What we’re especially excited about with this version is bringing together the work that has been going on in several collaborative initiatives and making it available to all the OnCore centers,"said Anthony O’Hare, PhD, Chief Scientific Officer at PercipEnz Technologies, Inc., creators of OnCore.
Version 10.0 includes functionality that was previously only available to research centers who were participating in specific collaborative initiatives. New functionality in OnCore includes support for multi-center trials, a new Affiliate Network Administration portal, enhanced communication and reporting tools, and additions to the OnCore Software Developers Toolkit (SDK) for integration with other systems such as those for electronic IRB management.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
